Login to Your Account



Verdict Favors Genentech In Chiron's Herceptin Suit

By Randall Osborne


Tuesday, September 10, 2002
Friday's quick, unanimous verdict favoring Genentech Inc. in the patent case filed by Chiron Corp. concerning the former's breast cancer drug Herceptin (trastuzumab) doesn't mean the case is closed. Hardly. (Bioworld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription